Skip to content
ChickenStockChickenStock
ResearchNMRA
Neumora Therapeutics logo

Neumora Therapeutics (NMRA) stock

NASDAQ

$0.33-9.49%(-0.04)

As of the Nov 17, 2026 close (U.S. Eastern)

Events and reference metrics · 1

Compares the share price with the company's earnings, net assets and sales. Check trading status and financial notes separately.

Price date for the multiples · Nov 17, 2026 · Financial period · Trailing twelve months

P/E and P/S use the latest four quarters where available · P/B uses the latest equity · Computed in-house by ChickenStock

P/E

-0.33x

Net loss — not comparable

P/B

3.32x

P/S

—

Find stocks with P/B ≤ 0.9×

Latest earnings

SEC filings

Jul–Sep 2026(FY2026 Q3)

Operating income increased from the same period a year earlier.

Key reported figures come first. Select one to see the same quarter across three years.

See the same quarter across three years →

Filed Nov 16, 2026 · 10-Q · SEC EDGAR

Reported results are from SEC EDGAR filings. Reference information only, not investment advice.

Insider transactions

Recent Form 4 filings grouped by person, date and transaction type.

27 SEC filings
  • Aurora Daljit SinghSee Remarks · Aug 21, 2026Open-market sale41,608 shares · $66K
    Avg. price $1.5954
    Show 2 price lots
    • 21,055 shares × $1.5958$34K
    • 20,553 shares × $1.5949$33K
  • Aurora Daljit SinghSee Remarks · Aug 21, 2026Option exercise41,608 shares · $30K
    Avg. price $0.72
    Show 2 price lots
    • 21,055 shares × $0.72$15K
    • 20,553 shares × $0.72$15K
  • Aurora Daljit SinghSee Remarks · Aug 20, 2026Open-market sale134,452 shares · $204K
    Avg. price $1.5142
    Show 2 price lots
    • 67,741 shares × $1.5144$103K
    • 66,711 shares × $1.514$101K
  • Aurora Daljit SinghSee Remarks · Aug 20, 2026Option exercise134,452 shares · $97K
    Avg. price $0.72
    Show 3 price lots
    • 67,741 shares × $0.72$49K
    • 45,026 shares × $0.72$32K
    • 21,685 shares × $0.72$16K
  • Aurora Daljit SinghSee Remarks · Aug 19, 2026Open-market sale61,918 shares · $102K
    Avg. price $1.646
    Show 2 price lots
    • 31,000 shares × $1.6461$51K
    • 30,918 shares × $1.6459$51K
  • Aurora Daljit SinghSee Remarks · Aug 19, 2026Option exercise61,918 shares · $45K
    Avg. price $0.72
    Show 3 price lots
    • 30,918 shares × $0.72$22K
    • 17,732 shares × $0.72$13K
    • 13,268 shares × $0.72$10K
  • Aurora Daljit SinghSee Remarks · Aug 18, 2026Open-market sale69,149 shares · $110K
    Avg. price $1.5853
    Show 2 price lots
    • 34,987 shares × $1.5859$55K
    • 34,162 shares × $1.5847$54K
  • Aurora Daljit SinghSee Remarks · Aug 18, 2026Option exercise69,149 shares · $50K
    Avg. price $0.72
    Show 2 price lots
    • 34,987 shares × $0.72$25K
    • 34,162 shares × $0.72$25K
  • Aurora Daljit SinghSee Remarks · Aug 17, 2026Open-market sale146,706 shares · $220K
    Avg. price $1.5005
    Show 3 price lots
    • 57,670 shares × $1.5055$87K
    • 55,016 shares × $1.5047$83K
    • 34,020 shares × $1.4853$51K
  • Aurora Daljit SinghSee Remarks · Aug 17, 2026Option exercise112,686 shares · $81K
    Avg. price $0.72
    Show 6 price lots
    • 40,890 shares × $0.72$29K
    • 29,737 shares × $0.72$21K
    • 25,279 shares × $0.72$18K
    • 15,355 shares × $0.72$11K
    • 1,424 shares × $0.72$1K
    • 1 shares × $0.72$1

Only transactions reported on SEC Form 4 are shown. A sale may follow a pre-arranged 10b5-1 plan, and items such as option exercises or shares withheld for taxes are not open-market trades.

Recent SEC filings

40 filings

Filings submitted to the U.S. Securities and Exchange Commission (EDGAR). Dates are SEC filing dates (U.S. Eastern). Form and item names are the official SEC titles. The Earnings and Risk tags come directly from form types and item codes; they are not written by AI. Insider ownership reports (Forms 3, 4 and 5) are excluded.

Company overview

Expand ▾

Neumora Therapeutics (NMRA) stock information

NASDAQ

Neumora Therapeutics (NMRA) is listed on NASDAQ. Its market capitalization is about $63M. On trailing-twelve-month earnings the P/E ratio is -0.33, and the P/B ratio is 3.32. Return on equity is -994.7%. These figures are computed in-house from official filings and are reference information only.

Neumora Therapeutics — frequently asked questions

What is the P/E ratio of Neumora Therapeutics (NMRA)?
On a trailing-twelve-month basis, NMRA trades at a P/E ratio of -0.33. It is calculated as market capitalization divided by net income attributable to controlling interests, using official filings. Reference information only.
What is the market capitalization of Neumora Therapeutics?
NMRA has a market capitalization of about $63M. The figure moves with the share price and is refreshed each trading day.
Is this page investment advice?
No. Every figure on this page is factual reference information compiled from public filings. It is not investment advice, not a price forecast and not a recommendation to buy or sell. Investment decisions rest with the user.

All metrics, scores, and content provided by ChickenStock are reference information derived from market data. They are not investment advice or a solicitation to trade. Investment decisions and their consequences rest with the user.